Emergency Contraception: Review and Update

  • Katharine Sznajder
  • Roxanne Jamshidi
Family Planning (A. Burke, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Family Planning


Unintended pregnancy continues to be a substantial public health problem. Emergency contraception (EC) provides a last chance at pregnancy prevention. Several safe and effective options for emergency contraception are currently available. The Yuzpe method, a combined hormonal regimen, was essentially replaced by other oral medications including levonorgestrel and the antiprogestin ulipristal. The antiprogestin mifepristone has been studied for use as emergency contraception. The most effective postcoital method of contraception is the copper intrauterine device (IUD). Obesity and the simultaneous initiation of progestin-containing contraception may decrease the effectiveness of some emergency contraception.


Emergency contraception Contraception Review 


Compliance with Ethical Standards

Conflict of Interest

Katharine Sznajder and Roxanne Jamshidi declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Leung VW, Levine M, Soon JA. Mechanisms of action of hormonal emergency contraceptives. Pharmacotherapy. 2010;30(2):158–68.CrossRefPubMedGoogle Scholar
  2. 2.
    Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8:389–92.PubMedGoogle Scholar
  3. 3.
    Task force on postovulatory methods of fertility regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352:428–433.Google Scholar
  4. 4.
    Ellertson C, Webb A, Blanchard K, et al. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet Gynecol. 2003;101:1160–7.CrossRefPubMedGoogle Scholar
  5. 5.•
    Cheng L, Che Y, Gulmezoglu AM. Interventions for emergency contraception. Cochrane Database Syst Rev. 2012;8:CD001324. Systematic review of randomized controlled trials and controlled clinical trials of emergency contraception methods including mifepristone, LNG, Yuzpe, ulipristal, and copper IUD.PubMedGoogle Scholar
  6. 6.
    von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicenter randomised trial. Lancet. 2002;360:1803–10.CrossRefGoogle Scholar
  7. 7.
    Noe G, Croxatto HB, Maria Salvatierra A, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception. 2011;84:486–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Novikova N, Weisberg E, Stanczyk FZ, et al. Effectiveness of levonorgestrel emergency contraception given before or after ovulation—a pilot study. Contraception. 2007;75:112–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Creinin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2006;108:1089–97.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375:555–62.CrossRefPubMedGoogle Scholar
  11. 11.•
    Brache V, Cochon L, Deniaud M, Croxatto H. Ulipristal acetate prevents ovulation more effectively than levonorgestrel—analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception. 2013;88(5):611–8. Pooled data from three pharmacokinetic studies show that ulipristal is more effective than LNG at inhibiting follicular rupture when administered in the late follicular phase. CrossRefPubMedGoogle Scholar
  12. 12.
    Gemzell-Danielsson K, Berger C, Lalitkumar PGL. Emergency contraception—mechanisms of action. Contraception. 2013;87:300–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Fine P, Mathe H, Ginde S, et al. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115:257–63.CrossRefPubMedGoogle Scholar
  14. 14.
    Turok DK, Godfrey EM, Wojdyla D, Dermish A, Torres L, Wu SC. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum Reprod. 2013;28:2672–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012;27:1994–2000.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Turok DK, Jacobson JC, Dermish AI, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception. 2014;89(3):222–8.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Carbonell JL, Garcia R, Gonzalez A, Breto A, Sanchez C. Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial. Int J Womens Health. 2015;7:95–102.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Kapp N, Abitbol J, Mathe H, et al. Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception. Contraception. 2015;91:97–104.CrossRefPubMedGoogle Scholar
  20. 20.
    Cleland K, Wood S. A tale of two label changes. Contraception. 2014;90(1):1–3.CrossRefPubMedGoogle Scholar
  21. 21.
    American Society for Emergency Contraception. Efficacy of emergency contraception and body weight: current understanding and recommendations. Available at: Accessed 11 Oct 2015.
  22. 22.•
    Gemzell-Danielsson K, Kardos L, von Hertzen H. Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials. Curr Med Res Opin. 2015;14:1–22. A meta-analysis of LNG EC used within 72 hours of unprotected intercourse which did not show an effect of obesity or high body weight on the efficacy of EC.Google Scholar
  23. 23.
    World Health Organization. Medical eligibility criteria for contraceptive use, 5th ed. 2015.Google Scholar
  24. 24.
    Centers for Disease Control and Prevention. US selected practice recommendations for contraceptive use, 2013: Adapted from the world health organization selected practice recommendations for contraceptive use, 2nd edition. Available at: Accessed 17 Oct 2015.
  25. 25.
    Faculty of sexual and reproductive healthcare (FSRH). Quick-start guidance. September 2010. Available at: Contraception.pdf. Last accessed 25 Oct 2015.
  26. 26.•
    Cameron ST, Berger C, Michie L, Klipping C, Gemzell-Danielsson K. The effects on ovarian activity of ulipristal acetate when ‘quickstarting’ a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. Hum Reprod. 2015;30(7):1566–72. A prospective randomized controlled trial showing no impact of ulipristal on the effectiveness of COC by measuring the effects on ovarian activity. The effects of COC on the efficacy of ulipristal was not studied.CrossRefPubMedGoogle Scholar
  27. 27.•
    Brache V, Cochon L, Duijkers IJ, Levy DP, Kapp N, Monteil C, et al. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. Hum Reprod. 2015 Sep 23. A pharmacodynamic study which shows that initiating a desogestrel progestin-only pill one day after administration of ulipristal may decrease the ability of ulipristal to delay ovulation. However, the converse was not true, i.e. ulipristal did not impact the contraceptive onset of the desogestrel progestin-only pill. Google Scholar
  28. 28.
    Glasier A. Starting hormonal contraception after using emergency contraception: what should we recommend? Hum Reprod. 2015 Sep 23.Google Scholar
  29. 29.
    Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use. MMWR. 2010;59:1–85.Google Scholar
  30. 30.
    Cleland K, Raymond E, Trussell J, Cheng L, Zhu H. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol. 2010;115:1263–6.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Farquhar CM. Ectopic pregnancy. Lancet. 2005;366(9485):583–91.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhang J, Li C, Zhao WH, Xi X, Cao SJ, Ping H, et al. Association between levonorgestrel emergency contraception and the risk of ectopic pregnancy: a multicenter case-control study. Sci Rep. 2015;5:8487.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Wanggren K, Stavreus-Evers A, Olsson C, et al. Regulation of muscular contractions in the human fallopian tube through prostaglandins and progestagens. Hum Reprod. 2008;23:2359–68.CrossRefPubMedGoogle Scholar
  34. 34.
    Mahmood T, Saridogan E, Smutna S, et al. The effect of ovarian steroids on epithelial ciliary beat frequency in the human fallopian tube. Hum Reprod. 1998;13:2991–4.CrossRefPubMedGoogle Scholar
  35. 35.
    Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol. 1990;76:552–7.PubMedGoogle Scholar
  36. 36.
    Zhang L, Ye W, Yu W, Cheng L, Shen L, Yang Z. Physical and mental development of children after levonorgestrel emergency contraception exposure: a follow-up prospective cohort study. Biol Reprod. 2014;91(1):27.CrossRefPubMedGoogle Scholar
  37. 37.
    Levy DP, Jager M, Kapp N, Abitbol JL. Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women. Contraception. 2014;89(5):431–3.CrossRefPubMedGoogle Scholar
  38. 38.
    Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM. Pregnancy outcomes with an IUD in situ: a systematic review. Contraception. 2012;85:131–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Sitruk-Ware R. Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception. 2006;74:48–55.CrossRefPubMedGoogle Scholar
  40. 40.
    Raymond E, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109:181–8.CrossRefPubMedGoogle Scholar
  41. 41.
    ESHRE Capri Workshop Group. Emergency contraception. Widely available and effective but disappointing as a public health intervention: a review. Hum Reprod. 2015;30(4):751–60.CrossRefGoogle Scholar
  42. 42.
    Shaaban OM, Hassen SG, Nour SA, Kames MA, Yones EM. Emergency contraceptive pills as a backup for lactational amenorrhea method (LAM) of contraception: a randomized controlled trial. Contraception. 2013;87:363–9.CrossRefPubMedGoogle Scholar
  43. 43.•
    Practice Bulletin No. 152: Emergency contraception. Obstet Gynecol. 2015 Sep;126(3):e1-e11. Excellent summary of emergency contraception with special attention to clinical considerations. Google Scholar
  44. 44.
    Moreau C, Bouyer J, Goulard H, Bajos N. The remaining barriers to the use of emergency contraception: perception of pregnancy risk by women undergoing induced abortions. Contraception. 2005;71(3):202–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Goulard H, Moreau C, Gilbert F, Job-Spira N, Bajos N. Cocon Group. Contraceptive failures and determinants of emergency contraception use. Contraception. 2006;74(3):208–13.CrossRefPubMedGoogle Scholar
  46. 46.
    Westley E, Kapp N, Palermo T, Bleck J. A review of global access to emergency contraception. Int J Gynaecol Obstet. 2013;123(1):4–6.CrossRefPubMedGoogle Scholar
  47. 47.
    American Society for Emergency Contraception. The cost of emergency contraception: Results from a nationwide survey. Available at: Accessed 11 Oct 2015.
  48. 48.
    Thompson K, Belden P. Counseling for emergency contraception: time for a tiered approach. Contraception. 2014;90(6):559–61.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Gynecology and Obstetrics, School of MedicineJohns Hopkins UniversityBaltimoreUSA
  2. 2.Department of Obstetrics and Gynecology, School of Medicine and Health SciencesGeorge Washington UniversityWashingtonUSA

Personalised recommendations